Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000149

SVP, Head of Manufacturing acquired 7,650 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
English Emily SVP, Head of Manufacturing 2024-12-26 Option exercise +7,650 $3.30 $25,245 25,923 D
Derivatives
English Emily SVP, Head of Manufacturing 2024-12-26 Option exercise · Stock Option (Right to Buy) −7,650 49,369 D
Loading xslF345X05/wk-form4_1735593112.xml…